UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005–2014

Radiotherapy and oncology, 2018-06, Vol.127 (3), p.501-506

2018

Volltextzugriff (PDF)

Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery

Acta neurochirurgica, 2021-02, Vol.163 (2), p.333-342

2021

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3068-3077

2000

Volltextzugriff (PDF)

SBRT of Large Tumors: A Retrospective Study

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015-11, Vol.93 (3), p.E481-E482

2015

Volltextzugriff (PDF)

Evaluation of third treatment week as temporal window for assessing responsiveness on repeated FDG-PET-CT scans in Non-Small Cell Lung Cancer patients

Physica medica, 2018-02, Vol.46, p.45-51

2018

Volltextzugriff (PDF)

Spatial Accuracy and Visibility Studies of a MRI Compatible Fiducial Marker

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S737-S738

2012

Volltextzugriff (PDF)

A Multinational Report on Technical Factors of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015-11, Vol.93 (3), p.E577-E578

2015

Volltextzugriff (PDF)

A Multinational Report on Factors of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: Patient Selection and Follow-up

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015-11, Vol.93 (3), p.E208-E209

2015

Volltextzugriff (PDF)

The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy

Journal of thoracic oncology, 2021-07, Vol.16 (7), p.1200-1210

2021

Volltextzugriff (PDF)

Comparison of the SBRT Frame Procedure versus Gold Anchor Fiducial Marker IGRT on Accuracy, Precision and Economy

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S863-S863

2011

Volltextzugriff (PDF)

Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors

International journal of radiation oncology, biology, physics, 2023-12, Vol.117 (5), p.1222-1231

2023

Volltextzugriff (PDF)

Fine-needle Marker for IGRT, a New Fiducial Gold Anchor for High-precision Radiotherapy

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, Vol.75 (3), p.S608-S609

2009

Volltextzugriff (PDF)

Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum

International journal of radiation oncology, biology, physics, 2005-03, Vol.61 (4), p.1035-1044

2005

Volltextzugriff (PDF)

Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions

Acta oncologica, 2019-08, Vol.58 (8), p.1178-1186

2019

Volltextzugriff (PDF)

Failures after operation for skeletal metastatic lesions of long bones

Clinical orthopaedics and related research, 1999 (358), p.128-139

1999

Volltextzugriff (PDF)

Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy

Radiotherapy and oncology, 2011-11, Vol.101 (2), p.260-266

2011

Volltextzugriff (PDF)

Fine-Needle Deposition of a New Multifunctional Gold Marker Anchor for Tumor Tracking

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, Vol.63 (2), p.S538-S538

2005

Volltextzugriff (PDF)

Impact of SBRT fractionation in hypoxia dose painting — Accounting for heterogeneous and dynamic tumor oxygenation

Medical physics (Lancaster), 2019-05, Vol.46 (5), p.2512-2521

2019

Volltextzugriff (PDF)

Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma

Future oncology (London, England), 2016-03, Vol.12 (5), p.637-645

2016

Volltextzugriff (PDF)

Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc - effects and side effects

Acta oncologica, 2021-04, Vol.60 (3), p.305-311

2021

Volltextzugriff (PDF)

Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience

Acta oncologica, 2015-01, Vol.54 (8), p.1096-1104

2015

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Journal of clinical oncology, 2023-08, Vol.41 (23), p.3881-3890

2023

Volltextzugriff (PDF)

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

British journal of cancer, 2004-08, Vol.91 (4), p.688-694

2004

Volltextzugriff (PDF)

Estimation of delivered dose to lung tumours considering setup uncertainties and breathing motion in a cohort of patients treated with stereotactic body radiation therapy

Physica medica, 2021-08, Vol.88, p.53-64

2021

Volltextzugriff (PDF)

Outcome After SBRT of Adrenal Gland Metastases: A Multicenter Retrospective Analysis of 60 Adrenal Metastases

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014-09, Vol.90 (1), p.S326-S326

2014

Volltextzugriff (PDF)

1 – 25 von 171

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005–2014

Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

SBRT of Large Tumors: A Retrospective Study

Evaluation of third treatment week as temporal window for assessing responsiveness on repeated FDG-PET-CT scans in Non-Small Cell Lung Cancer patients

Spatial Accuracy and Visibility Studies of a MRI Compatible Fiducial Marker

A Multinational Report on Technical Factors of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma

A Multinational Report on Factors of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: Patient Selection and Follow-up

The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy

Comparison of the SBRT Frame Procedure versus Gold Anchor Fiducial Marker IGRT on Accuracy, Precision and Economy

Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors

Fine-needle Marker for IGRT, a New Fiducial Gold Anchor for High-precision Radiotherapy

Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum

Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions

Failures after operation for skeletal metastatic lesions of long bones

Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy

Fine-Needle Deposition of a New Multifunctional Gold Marker Anchor for Tumor Tracking

Impact of SBRT fractionation in hypoxia dose painting — Accounting for heterogeneous and dynamic tumor oxygenation

Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma

Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc - effects and side effects

Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

Estimation of delivered dose to lung tumours considering setup uncertainties and breathing motion in a cohort of patients treated with stereotactic body radiation therapy

Outcome After SBRT of Adrenal Gland Metastases: A Multicenter Retrospective Analysis of 60 Adrenal Metastases

Suchergebnisse filtern